Boston Scientific (BSX)

Operating Cash Flow (Statement)

$1.47B

Quarterly · Period ending: · USD

BSX logo

BSX Operating Cash Flow (Statement)

Latest reported$1.47B
BSX Quarterly Cash from Operations ($11.40M → $1.47B)
High-resolution chart · PNG

BSX operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Boston Scientific Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
123,000,000
91,000,000
177,000,000
178,000,000
237,000,000
147,000,000
165,000,000
287,000,000
186,000,000
137,000,000
155,000,000
53,000,000
16,000,000
34,000,000
15,700,000
-3,100,000
1,500,000
66,400,000
52,400,000
61,200,000
-9,600,000
36,300,000
5,400,000
-20,000,000
8,200,000
31,400,000
19,100,000
16,000,000
10,400,000
22,300,000
17,000,000
19,400,000
11,600,000
17,800,000
10,300,000
15,400,000
5,400,000
11,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.